Illumina has partnered with Vitrolife to sell our preimplantation genetic screening (PGS) and karyomapping products. Please contact Vitrolife for any sales and support.
The VeriSeq PGS Kit takes advantage of next-generation sequencing (NGS) technology to provide comprehensive, accurate screening of all 24 chromosomes for identification of in vitro embryos most likely to be euploid. Preimplantation genetic screening (PGS) results generated using the VeriSeq PGS Kit are comparable to those achieved with the widely used array-based 24sure technology. In addition, NGS offers the opportunity for improved assay workflow, higher throughput, and enhanced performance.1
Learn more about preimplantation genetic screening.
VeriSeq NIPT Analysis Software (16 Samples)
Data Sheet | PDF < 1 MB
BlueFuse Multi Analysis Software for Preimplantation Genetic Screening
Data Sheet | PDF < 1 MB
BlueFuse Multi Analysis Software for Molecular Cytogenetics
Data Sheet | PDF < 1 MB
BlueFuse Multi Analysis Software for Preimplantation Genetic Diagnosis
Data Sheet | PDF 1 MB
VeriSeq PGS Library Prep Kit Support Documentation
BlueFuse Workflow Manager Quick Reference Card (15056206) Documentation
VeriSeq PGS Technical Guide to Aneuploidy Calling Documentation
BlueFuse Workflow Manager User Guide (1000000028842) Documentation
SurePlex Summary Protocol Reference Guide Documentation
Custom Protocol Selector
Generates customized, end-to-end instructions
The 24sure Microarray has been discontinued. VeriSeq PGS provides an alternative solution for this application. Illumina remains committed to providing you with high-quality support and service.
A next-generation sequencing solution that provides accurate chromosome screening for identification of in vitro embryos most likely to be euploid.
Used to generate a DNA template from single cells. Ideal for use with VeriSeq PGS applications.
Prepare sequencing libraries for small genomes, PCR amplicons, plasmids, or cDNA in as little as 90 minutes, with a low DNA input requirement.
Optimized chemistry to increase cluster density and read length, and improve sequencing quality scores, compared to earlier MiSeq reagent kit versions.
Comprehensive sequencing research panels targeting disease-associated regions of the exome with high analytical sensitivity and specificity.